Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: Evidence from Canada

8 Jan 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epilepsy research and treatment
Share to Genomics and Rare Diseases
Share to Lysosomal Storage Disorders Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38205742
DOI: 10.1016/j.gim.2024.101069

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: Evidence from CanadaPMID 38205742Read ↗

Cost-effectiveness of genome-wide sequencing for unexplained developmental disabilities and multiple congenital anomaliesSemantic proximity Read ↗

Epilepsy and developmental disorders: Next generation sequencing in the clinicSemantic proximity Read ↗

Cost-effectiveness of Genome and Exome Sequencing in Children Diagnosed with Autism Spectrum DisorderSemantic proximity Read ↗

Genetics of Pediatric Epilepsy: Next-Generation Sequencing in Clinical PracticeSemantic proximity Read ↗

Epilepsy panels in clinical practice: Yield, variants of uncertain significance, and treatment implications.Semantic proximity Read ↗

Clinical whole genome sequencing in pediatric epilepsy: Genetic and phenotypic spectrum of 733 individualsSemantic proximity Read ↗

Targeted gene sequencing in 6994 individuals with neurodevelopmental disorder with epilepsySemantic proximity Read ↗

A nationwide prospective randomized trial for diagnosing developmental disorders demonstrates genome sequencing outperforms standard of careSemantic proximity Read ↗

Genetic testing in paediatric neurological disordersSemantic proximity Read ↗

Exome sequencing as first-tier genetic testing in infantile-onset pharmacoresistant epilepsy: diagnostic yield and treatment impactSemantic proximity Read ↗

Exome first approach to reduce diagnostic costs and time – retrospective analysis of 111 individuals with rare neurodevelopmental disordersSemantic proximity Read ↗

Evidence review and considerations for use of first line genome sequencing to diagnose rare genetic disordersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.